Intellipharmaceutics

157 articles with Intellipharmaceutics

• Intellipharmaceutics Announces Patent Litigation By Purdue Pharma L.P. Against Its Rexista Abuse-Deterrent Extended-Release Oxycodone

  4/10/2017

• IntelliPharmaCeutics Announces TSX Trading Symbol Change To “IPCI”

  3/16/2017

• IntelliPharmaCeutics Announces FDA Approval For 500 Mg And 750 Mg Generic Glucophage XR

  2/24/2017

• IntelliPharmaCeutics Announces 2016 Year End Results

  2/10/2017

• IntelliPharmaCeutics Announces FDA Acceptance For Filing Of NDA For Rexista (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain

  2/3/2017

• IntelliPharmaCeutics Reports On Launch Of Additional Strengths Of Generic Focalin XR By Par Pharma

  1/6/2017

• IntelliPharmaCeutics Announces Issuance Of U.S. And Canadian Patents Covering Aspects Of Its PODRAS Overdose Technology

  12/21/2016

• IntelliPharmaCeutics Submits New Drug Application For Rexista® (Oxycodone Hydrochloride Extended Release), An Abuse Deterrent Opioid Analgesic For The Treatment Of Moderate To Severe Pain

  11/28/2016

• IntelliPharmaCeutics Announces Third Quarter 2016 Results

  10/14/2016

• IntelliPharmaCeutics Signs An Exclusive License And Commercial Supply Agreement With Mallinckrodt

  10/12/2016

• IntelliPharmaCeutics Announces FDA Tentative Approval for Generic Seroquel XR

  10/10/2016

• IntelliPharmaCeutics Responds To Recent Trading Activity

  9/23/2016

• IntelliPharmaCeutics To Present At The 18th Annual Rodman & Renshaw Global Investment Conference

  8/26/2016

• IntelliPharmaCeutics Announces Second Quarter 2016 Results

  7/13/2016

• IntelliPharmaCeutics Reports Update On Rexista XR: FDA Grants Waiver Of NDA Filing Fee, And Topline Pharmacokinetics Results Indicate No Food Effect

  7/5/2016

• IntelliPharmaCeutics Announces Pricing Of $5.2 Million Public Offering Of Common Shares And Warrants

  5/27/2016

• IntelliPharmaCeutics Announces FDA Approval For 500 Mg And 750 Mg Generic Keppra XR®

  2/25/2016

• IntelliPharmaCeutics To Present At The Biotech Showcase

  12/22/2015

• IntelliPharmaCeutics To Present At The LD Micro Main Event

  11/25/2015

• IntelliPharmaCeutics To Present At The Microcap Conference

  10/27/2015